Press Releases
The Babraham Institute's External Relations Office is responsible for the communication strategy and corporate profile of the Babraham Group. The office facilitates communication with the media and promotes effective networking with the bioscience community and our stakeholders.
All media enquiries should be made to the External Relations Office:
Dr Claire Cockcroft
Head of External Relations
Tel: +44 (0) 1223 496260 Email
2010
25th August 2010
Antitope Announces Research Collaboration with Ablynx
19th July 2010
Antitope Announces EpiScreen™ Collaboration with PIKAMAB
19th July 2010
Babraham Bioscience Technologies attracts another monoclonal antibody company to the Babraham Research Campus
28th May 2010
Babraham’s 7th Biotechnology Investment Forum fosters finance opportunities
25th May 2010
Next-generation disease-modifying drugs for Alzheimer's enter pre-clinical development
26th April 2010
Senexis launches new website
Indian Stem Cell Companies explore collaborative opportunities with Cambridge
16th February 2010
Babraham Research Campus wins EEDA Capital Equipment Grant to accelerate drug discovery
11th January 2010
Clive Dix Appointed as Chairman of Crescendo Biologics
6th January 2010
f-star raises €8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures
2009
15th December 2009
Babraham announces new Bioincubator Building Programme for 2010
13th November 2009
SENEXIS FILES NEW PATENTS TO PROTECT NOVEL ALZHEIMER’S COMPOUNDS
11th November 2009
New website links enterprise activities across Cambridge
30th October 2009
SENEXIS NOVEL APPROACH WINS ERBI AWARD FOR INNOVATION
12th October 2009
Mike Romanos Appointed as CSO of Crescendo Biologics
12th October 2009
Crescendo Biologics Raises £4.5 million in Seed-Funding
4th September 2009
SENEXIS TO SELECT DEVELOPMENT CANDIDATE FROM ITS SMALL MOLECULE
ALZHEIMER’S COMPOUNDS WITH FUNDING FROM THE WELLCOME TRUST
26th August 2009
SENEXIS RECEIVES GRAD AWARD FROM EEDA TO SELECT A NOVEL ALZHEIMER’S DRUG
15th May 2009
Babraham Bioscience Technologies Ltd appoints Derek Jones as CEO
13th May 2009
Babraham-based Innova Biosciences strikes an alliance with Cancer Research Technology
16th February 2009
Innova Biosciences Awarded EU Grant to Develop Cancer Biomarker Discovery Platform
10th February 2009
Rapid Biosensor Systems: A Revolution in TB Screening
2008
11th December 2008
Cancer Companies at Babraham's Bioincuabtor win Major Awards for Medical Innovation
10th December 2008
Senexis to collaborate with Alzhyme on Alzheimer's diagnostics
4th December 2008
Minister for the East of England visits the Babraham Research Campus and new Technology Development Laboratory
10th September 2008
Pronostics to supply Hannover Medical School with next generation diagnostics for autoimmune disease
5th September 2008
ImmBio-Led Consortium Releases Promising Data for Meningitis B Vaccine
25th July 2008
Pronostics set for European expansion with digital multiplexing solution
18th June 2008
MedCell and NovaThera Merge
9th May 2008
Babraham's 5th Biotechnology Investment Forum draws French Biotech Companies
6th May 2008
Isogenica completes acquisition of the principal assets of Karyon CTT
4th April 2008
Biovitrum's unique neuropathic pain compound is very safe and shows positive effect
1st April 2008
NOVAPOD™ - Anglo-China Manufacturing Agreement Signed Following Market Success
13th March 2008
NovaThera signs Licensing Agreement for 3D Stem Differentiation and Production
12th March 2008
Antibody Engineering Company F-Star Opens Second Research Site in Cambridge, UK
12th March 2008
Pronostics signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe's largest diagnostics market
19th February 2008
Population Genetics Technologies Raises £3.8M in Series A Funding; Appoints Mel N. Kronick Chief Executive Officer
15th February 2008
Stem Cell Sciences Implements Strategic Reorganisation
14th February 2008
Senexis and O2H (Oxygen Healthcare) announce medicinal chemistry collaboration
6th February 2008
Probe Scientific takes a major step forward with development and distribution plans
30th January 2008
Stem Cell Sciences Enters Agreement with Myelin Repair Foundation to Develop Sustainable Cell Sources for CNS Drug Discovery
17th January 2008
Senexis Raises £3.7M from the Wellcome Trust & BTG to Further Develop its Small Molecule Alzheimer's Compounds
2007
17th December 2007
Aitua Ltd Portfolio Company Establishes Worldwide Distributor Network
13th December 2007
Antitope Limited UK announces EpiScreen™ collaboration with UCB
29th November 2007
Traditional Chinese Medicine Company announced as the 50th Company to join the Babraham Bioincubator at the official opening of 'Meditrina'
21st November 2007
Biotechnology Investment Forum bridges the bioclusters in Babraham and Boston, USA
20th November 2007
Babraham and JETRO Cooperate to bring Japanese Bioventures to the Cambridge Region
15th November 2007
NovaPodT -A New Device for Stem Cell Applications
15th October 2007
NovaThera Research Expansion
8th October 2007
NovaTex™ a new nanoglass textile material for medical applications
25th September 2007
Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology
21st August 2007
SCS Consolidates Business Through Technology Buy-Back
26th July 2007
New Bioincubation Facilities on the Babraham Research Campus set to open in September 2007
2nd July 2007
NovaThera Limited announces appointment of Dr John Beadle as CEO
9th May 2007
NovaThera and Gamida Cell Announce a Collaboration Agreement
